Series B startups in Cambridge, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| UltraSight | Cambridge | Series B | $24.0M | 2026-09-23 |
| Simnova | Cambridge | Series B | $59.3M | 2026-08-18 |
| Elemental Machines | Cambridge | Series B | $5.7M | 2026-05-27 |
| JuliaHub | Cambridge | Series B | $65.0M | 2026-04-30 |
| Kytopen | Cambridge | Series B | $1.6M | 2026-04-07 |
| Atavistik Bio | Cambridge | Series B | $40.0M | 2026-03-05 |
| Nocion Therapeutics | Cambridge | Series B | $23.0M | 2026-01-07 |
| PineTree Therapeutics | Cambridge | Series B | $47.0M | 2025-10-28 |
8 rows of the CSV in 5 of its 18 columns.
- The 106 series b startups in Cambridge, Massachusetts have raised $9.3B in total.
- 14 of them closed their most recent round in the last 12 months, $827.1M combined.
- The largest of those rounds is Matchpoint Therapeutics' $150.0M Series B, dated October 2026.
- National Science Foundation is an investor in 3 of them, more than any other fund.
- Health care is the most common sector, with 75 companies (71%).
- 18% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (49% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
17 of 106| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| UltraSight | UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. | Health care | Series B | $24.0M | 2026-09-23 | $39.0M | Yozma Group | 11 to 50 | 2018 |
| Simnova | Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. | Biotech | Series B | $59.3M | 2026-08-18 | $87.2M | Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 | 51 to 100 | 2019 |
| Elemental Machines | Elemental Machines provides data-driven insights to improve research, laboratory operations, and manufacturing outcomes. | Artificial intelligence | Series B | $5.7M | 2026-05-27 | $66.5M | Founders Fund, Tau Ventures, Rock Health Capital +2 | 11 to 50 | 2015 |
| JuliaHub | JuliaHub provides a single platform for modeling, simulation, and building custom applications. | Software | Series B | $65.0M | 2026-04-30 | $107.8M | General Catalyst, National Science Foundation, Menlo Ventures +2 | 101 to 250 | 2015 |
| Kytopen | Kytopen develops genome engineering platforms for cell therapy research and manufacturing. | Biotech | Series B | $1.6M | 2026-04-07 | $39.1M | National Science Foundation, MassVentures, Alexandria Venture Investments +1 | 11 to 50 | 2017 |
| Atavistik Bio | Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. | Biotech | Series B | $40.0M | 2026-03-05 | $260.0M | Lux Capital, The Column Group, Nextech Invest | 11 to 50 | 2021 |
| Nocion Therapeutics | Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. | Biotech | Series B | $23.0M | 2026-01-07 | $134.0M | Canaan Partners, F-Prime, OUP (Osage University Partners) +2 | 11 to 50 | 2017 |
| Epicore Biosystems | Epicore Biosystems develops sweat-sensing wearables that deliver personalized health insights. | Hardware | Series B | $6.0M | 2025-05-01 | $41.9M | Alumni Ventures, National Institutes of Health, Joyance Partners +1 | 11 to 50 | 2017 |
| AIRNA | AIRNA develops RNA editing technologies to create medicines for various diseases. | Biotech | Series B | $155.0M | 2025-04-01 | $245.0M | ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 | 51 to 100 | 2021 |
| Pickle Robot | Pickle Robot supplies AI-enabled robotic systems that unload trailers and containers. | Artificial intelligence | Series B | $50.0M | 2024-11-11 | $102.5M | BoxGroup, DCVC, Toyota Ventures +2 | 101 to 250 | 2018 |
| NextPoint Therapeutics | NextPoint Therapeutics develops therapeutics to treat cancer patients as a clinical-stage biotechnology company. | Biotech | Series B | $42.5M | 2024-02-14 | $122.5M | Invus, Leaps by Bayer, Catalio Capital Management +2 | 51 to 100 | 2020 |
| ROME Therapeutics | ROME Therapeutics develops therapies for cancer and autoimmune diseases by targeting the repeatome. | Biotech | Series B | $72.0M | 2023-09-12 | $199.0M | Andreessen Horowitz, Google Ventures, Alexandria Venture Investments +2 | 11 to 50 | 2020 |
| ISEE | ISEE develops autonomous driving software and hardware to improve logistics processes. | Artificial intelligence | Series B | $40.0M | 2022-11-15 | $57.7M | Founders Fund, Eniac Ventures, The Engine +1 | 51 to 100 | 2017 |
| InsideTracker | InsideTracker provides a platform that analyzes and tracks key biochemical and physiological markers. | Biotech | Series B | $15.0M | 2022-09-06 | $18.2M | OurCrowd, MassVentures, Puget Sound Venture Club +2 | 11 to 50 | 2009 |
| Empatica | Empatica develops affective computing technology and human data analytics. | Artificial intelligence | Series B | $25.9M | 2022-08-02 | $35.6M | Bossa Invest, Endeavor Catalyst, RA Capital Management +2 | 101 to 250 | 2011 |
| Insurify | Insurify is an insurance agency offering auto, home, and life insurance. | Artificial intelligence | Series B | $100.0M | 2021-09-01 | $129.6M | Hearst Ventures, Moneta VC, R136 Ventures +2 | 101 to 250 | 2013 |
| ReversingLabs | ReversingLabs provides file and software security solutions that organizations rely on. | Cybersecurity | Series B | $56.0M | 2021-08-05 | $81.0M | IQT, JP Morgan Chase, Forgepoint Capital +2 | 251 to 500 | 2009 |
Table 1. Series B startups in Cambridge, Massachusetts: the 17 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 106.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JuliaHub | JuliaHub provides a single platform for modeling, simulation, and building custom applications. | Software | Series B | $65.0M | 2026-04-30 | $107.8M | General Catalyst, National Science Foundation, Menlo Ventures +2 | 101 to 250 | 2015 |
| 2 | Simnova | Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. | Biotech | Series B | $59.3M | 2026-08-18 | $87.2M | Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 | 51 to 100 | 2019 |
| 3 | Atavistik Bio | Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. | Biotech | Series B | $40.0M | 2026-03-05 | $260.0M | Lux Capital, The Column Group, Nextech Invest | 11 to 50 | 2021 |
| 4 | UltraSight | UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. | Health care | Series B | $24.0M | 2026-09-23 | $39.0M | Yozma Group | 11 to 50 | 2018 |
| 5 | Nocion Therapeutics | Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. | Biotech | Series B | $23.0M | 2026-01-07 | $134.0M | Canaan Partners, F-Prime, OUP (Osage University Partners) +2 | 11 to 50 | 2017 |
| 6 | Elemental Machines | Elemental Machines provides data-driven insights to improve research, laboratory operations, and manufacturing outcomes. | Artificial intelligence | Series B | $5.7M | 2026-05-27 | $66.5M | Founders Fund, Tau Ventures, Rock Health Capital +2 | 11 to 50 | 2015 |
| 7 | Kytopen | Kytopen develops genome engineering platforms for cell therapy research and manufacturing. | Biotech | Series B | $1.6M | 2026-04-07 | $39.1M | National Science Foundation, MassVentures, Alexandria Venture Investments +1 | 11 to 50 | 2017 |
Table 2. Series B startups in Cambridge, Massachusetts: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 3 | 3% | 2 | JuliaHub, Kytopen |
| 2 | General Catalyst | Venture capital firm | San Francisco, United States | 3 | 3% | 1 | JuliaHub |
| 3 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 3 | 3% | 1 | Kytopen |
| 4 | Founders Fund | Venture capital firm | San Francisco, United States | 2 | 2% | 1 | Elemental Machines |
| 5 | IQT | Startup accelerator | Arlington, United States | 2 | 2% | 1 | JuliaHub |
| 6 | The Engine | Venture capital firm | Cambridge, United States | 2 | 2% | 1 | Kytopen |
| 7 | MassVentures | Venture capital firm | Boston, United States | 2 | 2% | 1 | Kytopen |
| 8 | Lux Capital | Venture capital firm | New York, United States | 2 | 2% | 1 | Atavistik Bio |
| 9 | OUP (Osage University Partners) | University program | Bala Cynwyd, United States | 2 | 2% | 1 | Nocion Therapeutics |
| 10 | F-Prime | Venture capital firm | Cambridge, United States | 2 | 2% | 1 | Nocion Therapeutics |
| 11 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 2 | 2% | ||
| 12 | RA Capital Management | Startup incubator | Boston, United States | 2 | 2% | ||
| 13 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 2 | 2% | ||
| 14 | Casdin Capital | Venture capital firm | New York, United States | 2 | 2% | ||
| 15 | Yozma Group | Government investment office | Tel Aviv, Israel | 1 | 1% | 1 | UltraSight |
Table 3. Series B startups in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 75 | 71% | $8.2B |
| Biotech | 68 | 64% | $7.9B |
| Software | 26 | 25% | $1.3B |
| Artificial intelligence | 13 | 12% | $955.8M |
| Hardware | 10 | 9% | $394.5M |
| Commerce | 4 | 4% | $140.4M |
| Education | 2 | 2% | $29.3M |
| Cybersecurity | 2 | 2% | $89.6M |
| Fintech | 1 | 1% | $129.6M |
Table 4. Series B startups in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 106 | 100% | $32.0M |
Table 5. Series B startups in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 7% | $150.0M |
| September 2026 | 1 | 7% | $24.0M |
| August 2026 | 1 | 7% | $59.3M |
| June 2026 | 2 | 14% | $161.5M |
| May 2026 | 2 | 14% | $127.7M |
| April 2026 | 2 | 14% | $66.6M |
| March 2026 | 2 | 14% | $117.0M |
| January 2026 | 3 | 21% | $121.0M |
Table 6. Series B startups in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 14 | 13% | $827.1M |
| 2025 | 7 | 7% | $582.0M |
| 2024 | 4 | 4% | $212.5M |
| 2023 | 10 | 9% | $862.0M |
| 2022 | 7 | 7% | $452.9M |
| 2021 | 12 | 11% | $1.1B |
Table 7. Series B startups in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 3% |
| 2020 to 2022 | 16 | 15% |
| 2015 to 2019 | 36 | 34% |
| 2010 to 2014 | 19 | 18% |
| Before 2010 | 32 | 30% |
Table 8. Series B startups in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 12 | 12% |
| 11 to 50 | 51 | 49% |
| 51 to 100 | 24 | 23% |
| 101 to 250 | 11 | 11% |
| 251 to 500 | 2 | 2% |
| 501 to 1,000 | 1 | 1% |
| 5,001 to 10,000 | 2 | 2% |
| 10,001 or more | 1 | 1% |
Table 9. Series B startups in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series B and its headquarters is in Cambridge, Massachusetts. On 16 November 2026 that is 106 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 17 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 106 rows: 2 have no round amount, 0 no city and 10 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series b startups in Cambridge, Massachusetts are on the list?
- 106, in the file dated 16 November 2026. 14 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 106 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.